Persistent Trichomoniasis in Pregnancy: A Case Report Calling for Further Research to Alternative Antibiotic Treatment
- PMID: 40242693
- PMCID: PMC12001296
- DOI: 10.7759/cureus.80702
Persistent Trichomoniasis in Pregnancy: A Case Report Calling for Further Research to Alternative Antibiotic Treatment
Abstract
Trichomoniasis is an STI caused by a microscopic parasite known as Trichomonas vaginalis. It is considered one of the most widespread nonviral STDs globally. Trichomoniasis during pregnancy can lead to complications such as early rupture of membranes and premature birth. The standard treatment for trichomoniasis in adults, including pregnant individuals, is metronidazole. Recurrent cases may occur due to factors such as incomplete treatment, reinfection, or metronidazole resistance. In cases of persistent trichomoniasis where noncompliance and reinfection have been ruled out, metronidazole resistance should be considered. We present the case of a 39-year-old woman, gravida 4, para 3, with persistent trichomoniasis unresponsive to multiple courses of metronidazole, suggesting potential metronidazole resistance. She experienced recurrent symptoms of threatened preterm labor, likely due to uterine irritability caused by trichomoniasis. While various treatment regimens are available for metronidazole resistance, their safety profiles have not been evaluated during pregnancy. Further research is essential to identify a safe and effective treatment for metronidazole-resistant trichomoniasis in pregnancy.
Keywords: metronidazole resistance; metronidazole-resistant trichomoniasis; persistent trichomoniasis; preterm birth; recurrent trichomoniasis infection; sexually transmitted diseases; threatened preterm labor; trichomonas vaginalis; trichomoniasis; trichomoniasis in pregnancy.
Copyright © 2025, Sabet et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Human Research Ethics Committee issued approval Ex64-24_113921. This project was reviewed by the Human Research Ethics Committee Chair and approved for exemption for ethics approval. It was deemed compliant with the NHMRC guidance “Ethical Consideration in Quality Assurance and Evaluation Activities” 2014. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9. J Obstet Gynaecol Can. 2015. PMID: 26001874
-
A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.Int J STD AIDS. 2016 Sep;27(10):906-8. doi: 10.1177/0956462415601295. Epub 2015 Sep 18. Int J STD AIDS. 2016. PMID: 26384945
-
Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.Cell Res. 2003 Aug;13(4):239-49. doi: 10.1038/sj.cr.7290169. Cell Res. 2003. PMID: 12974614 Review.
-
[Therapeutic aspects of trichomoniasis].Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):156-61. doi: 10.2298/sarh0304156v. Srp Arh Celok Lek. 2003. PMID: 14608880 Serbian.
-
Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: 10.1586/14787210.2014.887440. Epub 2014 Feb 20. Expert Rev Anti Infect Ther. 2014. PMID: 24555561 Review.
References
Publication types
LinkOut - more resources
Full Text Sources